Vilazodone Film-Coated Tablets Suppliers & Bulk Manufacturers
Available Forms: Film-Coated Tablets
Available Strengths: 10 mg, 20 mg, 40 mg
Reference Brands: Viibryd(US)
Category:
Psychiatry / Mental Health
Vilazodone is a selective serotonin reuptake inhibitor (SSRI) and partial 5-HT1A receptor agonist. It increases serotonin levels in the brain, improving mood and emotional balance. Approved for major depressive disorder (MDD) in adults, vilazodone offers antidepressant efficacy with a potentially lower risk of sexual side effects compared to traditional SSRIs.
Vilazodone Film-Coated Tablets is available in Film-Coated Tablets
and strengths such as 10 mg, 20 mg, 40 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Vilazodone Film-Coated Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Vilazodone Film-Coated Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Vilazodone film-coated tablets are FDA-approved in the United States for the treatment of major depressive disorder (MDD) in adults. It combines SSRI activity with 5-HT1A partial agonism, offering a unique antidepressant profile. U.S. regulatory requirements include a Boxed Warning for increased risk of suicidal thoughts in young adults, GMP-compliant manufacturing, and bioequivalence data for generics. In the European Union, vilazodone is not widely marketed but may be accessed via special import pathways or national applications. EU dossier submission would require Risk Management Plans (RMPs), clinical safety data, and pharmacovigilance commitments. For global sourcing and regulatory-ready supply, visit Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing